SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial

Journal:

Human Reproduction

Published:

2025-07-03

DOI:

10.1093/humrep/deaf082

Affiliations:

14

Authors:

18

Go to article

Institutions	Authors	Share
Hengrui, China	5.000000	0.28
Peking University Third Hospital (PUTH), PKUHSC, China	3.000000	0.17
Tongji Hospital (TJH), HUST, China	1.000000	0.06
The General Hospital, TMU, China	1.000000	0.06
Tangdu Hospital, China	1.000000	0.06
West China Second University Hospital of Sichuan University (WCSUH), SCU, China	1.000000	0.06
First Affiliated Hospital, AHMU, China	1.000000	0.06
The Sixth Affiliated Hospital, SYSU, China	1.000000	0.06
Shengjing Hospital of China Medical University, China	1.000000	0.06
Third Affiliated Hospital, ZZU, China	1.000000	0.06
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China	1.000000	0.06
Xiangya Hospital, CSU, China	1.000000	0.06

Interested in Reproductive Medicine?